NfL does not represent a biomarker specific to PD because other neurodegenerative diseases (i.e., multiple sclerosis, prion diseases, amyotrophic lateral sclerosis, AD, Huntington’s disease, and traumatic brain injury) share an increase in circulating levels of NfL [120,122]. This evidence concerns the gene NEFL and Parkinson disease.